Loading provider…
Loading provider…
Ophthalmology Physician in Nashville, TN
NPI: 1124387709Primary Practice Location
VANDERBILT UNIVERSITY MEDICAL CENTER
2200 Childrens Way, Nashville, TN
Primary Employer
Vanderbilt Medical Group
vanderbilthealth.com
HQ Phone
Get MD, MPH, CPH Sapna's Phone Numberphone_androidMobile
Get MD, MPH, CPH Sapna's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License

American Board of Ophthalmology
Ophthalmology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 310 | 471 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 183 | 263 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 162 | 194 |
| 4 | 67028Injection of drug into eye | 153 | 337 |
| 5 | J9035Injection, bevacizumab, 10 mg | 67 | 127 |
Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.
Incidence of and Risk Factors for Cataract in Anterior Uveitis.
Authors: James Rosenbaum, Nirali Bhatt, Grace Levy-Clarke, Jennifer Thorne, Eric Suhler
Journal: Am J Ophthalmol
Publication Date: 2023-07-05
Lead Sponsor: JHSPH Center for Clinical Trials
Intervention / Treatment: BIOLOGICAL: Adalimumab (ADA), DRUG: Conventional immunosuppression (CON)
Lead Sponsor: JHSPH Center for Clinical Trials
Collaborators: National Eye Institute (NEI)
Intervention / Treatment: DRUG: Dexamethasone intravitreal implant 0.7 mg, DRUG: Intravitreal Methotrexate 400 µg, DRUG: Intravitreal Ranibizumab 0.5 mg
Lead Sponsor: Vanderbilt University Medical Center
Intervention / Treatment: OTHER: Non invasive visual acuity testing